Janet Hammond
Corporate Officer/Principal bij ATEA PHARMACEUTICALS, INC.
Vermogen: 142 862 $ op 31-03-2024
Profiel
Janet Hammond is currently the Chief Development Officer at Atea Pharmaceuticals, Inc. and Vice President-Translational Medicine at Roche Ltd.
She previously worked as the Group Director-Virology Clinical Research at Bristol Myers Squibb Co., Chief Medical Officer, SVP & Head-Medical Affairs at Bausch Health Americas, Inc., SVP & Head-China Infectious Disease at F.
Hoffmann-La Roche Ltd., VP, Head-General Medicine & Infectious Disease at AbbVie, Inc., Head-Clinical Discovery at GSK Plc, and Senior Clinical Research Physician at Glaxo Wellcome, Inc. Hammond holds a doctorate from the University of Cape Town and a graduate degree from Johns Hopkins Bloomberg School of Public Health.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-02-2024 | 35 362 ( 0.04% ) | 142 862 $ | 31-03-2024 |
Actieve functies van Janet Hammond
Bedrijven | Functie | Begin |
---|---|---|
ATEA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2020 |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Corporate Officer/Principal | 29-03-2011 |
Eerdere bekende functies van Janet Hammond
Bedrijven | Functie | Einde |
---|---|---|
ABBVIE INC. | Corporate Officer/Principal | 01-08-2020 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01-11-2016 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 12-09-2011 |
BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Opleiding van Janet Hammond
University of Cape Town | Doctorate Degree |
Johns Hopkins Bloomberg School of Public Health | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ABBVIE INC. | Health Technology |
ATEA PHARMACEUTICALS, INC. | Health Technology |
GSK PLC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Finance |
Glaxo Wellcome, Inc. | Health Technology |